BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11809867)

  • 1. A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.
    Gessi S; Varani K; Merighi S; Cattabriga E; Iannotta V; Leung E; Baraldi PG; Borea PA
    Mol Pharmacol; 2002 Feb; 61(2):415-24. PubMed ID: 11809867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [(3)H]MRE 3008F20: a novel antagonist radioligand for the pharmacological and biochemical characterization of human A(3) adenosine receptors.
    Varani K; Merighi S; Gessi S; Klotz KN; Leung E; Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Borea PA
    Mol Pharmacol; 2000 May; 57(5):968-75. PubMed ID: 10779381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological and biochemical characterization of A3 adenosine receptors in Jurkat T cells.
    Gessi S; Varani K; Merighi S; Morelli A; Ferrari D; Leung E; Baraldi PG; Spalluto G; Borea PA
    Br J Pharmacol; 2001 Sep; 134(1):116-26. PubMed ID: 11522603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line.
    Merighi S; Varani K; Gessi S; Cattabriga E; Iannotta V; Ulouglu C; Leung E; Borea PA
    Br J Pharmacol; 2001 Nov; 134(6):1215-26. PubMed ID: 11704641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of A(3) adenosine receptors in human neutrophils and low frequency electromagnetic fields.
    Varani K; Gessi S; Merighi S; Iannotta V; Cattabriga E; Pancaldi C; Cadossi R; Borea PA
    Biochem Pharmacol; 2003 Nov; 66(10):1897-906. PubMed ID: 14599547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells.
    Fossetta J; Jackson J; Deno G; Fan X; Du XK; Bober L; Soudé-Bermejo A; de Bouteiller O; Caux C; Lunn C; Lundell D; Palmer RK
    Mol Pharmacol; 2003 Feb; 63(2):342-50. PubMed ID: 12527805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]-SCH 58261 labelling of functional A2A adenosine receptors in human neutrophil membranes.
    Varani K; Gessi S; Dionisotti S; Ongini E; Borea PA
    Br J Pharmacol; 1998 Apr; 123(8):1723-31. PubMed ID: 9605581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation.
    Gessi S; Varani K; Merighi S; Cattabriga E; Avitabile A; Gavioli R; Fortini C; Leung E; Mac Lennan S; Borea PA
    Mol Pharmacol; 2004 Mar; 65(3):711-9. PubMed ID: 14978250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and preliminary biological evaluation of [3H]-MRE 3008-F20: the first high affinity radioligand antagonist for the human A3 adenosine receptors.
    Baraldi PG; Cacciari B; Romagnoli R; Varani K; Merighi S; Gessi S; Borea PA; Leung E; Hickey SL; Spalluto G
    Bioorg Med Chem Lett; 2000 Feb; 10(3):209-11. PubMed ID: 10698437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine receptors in colon carcinoma tissues and colon tumoral cell lines: focus on the A(3) adenosine subtype.
    Gessi S; Merighi S; Varani K; Cattabriga E; Benini A; Mirandola P; Leung E; Mac Lennan S; Feo C; Baraldi S; Borea PA
    J Cell Physiol; 2007 Jun; 211(3):826-36. PubMed ID: 17348028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KF26777 (2-(4-bromophenyl)-7,8-dihydro-4-propyl-1H-imidazo[2,1-i]purin-5(4H)-one dihydrochloride), a new potent and selective adenosine A3 receptor antagonist.
    Saki M; Tsumuki H; Nonaka H; Shimada J; Ichimura M
    Eur J Pharmacol; 2002 May; 444(3):133-41. PubMed ID: 12063073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils.
    Visser SS; Theron AJ; Ramafi G; Ker JA; Anderson R
    Biochem Pharmacol; 2000 Oct; 60(7):993-9. PubMed ID: 10974209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human A2A adenosine receptors with the antagonist radioligand [3H]-SCH 58261.
    Dionisotti S; Ongini E; Zocchi C; Kull B; Arslan G; Fredholm BB
    Br J Pharmacol; 1997 Jun; 121(3):353-60. PubMed ID: 9179373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of A(3) adenosine receptor induces calcium entry and chloride secretion in A(6) cells.
    Reshkin SJ; Guerra L; Bagorda A; Debellis L; Cardone R; Li AH; Jacobson KA; Casavola V
    J Membr Biol; 2000 Nov; 178(2):103-13. PubMed ID: 11083899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of human A(2B) adenosine receptors: radioligand binding, western blotting, and coupling to G(q) in human embryonic kidney 293 cells and HMC-1 mast cells.
    Linden J; Thai T; Figler H; Jin X; Robeva AS
    Mol Pharmacol; 1999 Oct; 56(4):705-13. PubMed ID: 10496952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioligand binding and functional responses of ligands for human recombinant adenosine A(3) receptors.
    Yates L; Clark JH; Martin TJ; James S; Broadley KJ; Kidd EJ
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):191-200. PubMed ID: 16553647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the adenosinergic system in lung fibrosis.
    Della Latta V; Cabiati M; Rocchiccioli S; Del Ry S; Morales MA
    Pharmacol Res; 2013 Oct; 76():182-9. PubMed ID: 23994158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive coupling of atypical adenosine A3 receptors on human eosinophils to adenylyl cyclase.
    Ezeamuzie CI; Philips E
    Biochem Biophys Res Commun; 2003 Jan; 300(3):712-8. PubMed ID: 12507508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding thermodynamics at the human A(3) adenosine receptor.
    Merighi S; Varani K; Gessi S; Klotz KN; Leung E; Baraldi PG; Borea PA
    Biochem Pharmacol; 2002 Jan; 63(2):157-61. PubMed ID: 11841789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cl-IB-MECA [2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide] reduces ischemia/reperfusion injury in mice by activating the A3 adenosine receptor.
    Ge ZD; Peart JN; Kreckler LM; Wan TC; Jacobson MA; Gross GJ; Auchampach JA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1200-10. PubMed ID: 16985166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.